Rationale for (-)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changes.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/4BC9AD6D.svg?ark=w1%2F20260515%2F4BC9AD6D)](https://nobleid.org/work/w1/20260515/4BC9AD6D)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors